CXCL10 and adult-onset Still disease: Furthermore, we identified CCL8 and CXCL10 as potential biomarkers for AOSD-MAS because they were the most upregulated secretory molecules in AOSD-MAS patients in the response to virus pathway (Fig. 4E).